What is Tirzepatide?
Dual-action weight loss medication for medically supervised weight management
GLP-1/GIP Receptor Agonist
What is Tirzepatide?
Tirzepatide is a medication designed to help with weight management and managing type 2 diabetes. Tirzepatide works by mimicking two natural hormones in the body, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which help regulate appetite, blood sugar levels, and digestion.
By reducing hunger and improving how your body processes sugar, Tirzepatide supports weight management when combined with a healthy diet and exercise. Our compounded Tirzepatide is prepared by FDA-registered 503A compounding pharmacies. Compounded medications are not FDA-approved and may differ in effectiveness, side effects, and risk profile compared to FDA-approved brand-name medications.
Individual results vary based on factors such as starting weight, diet, exercise habits, and adherence to treatment. Your healthcare provider will help set realistic expectations.
By reducing hunger and improving how your body processes sugar, Tirzepatide supports weight management when combined with a healthy diet and exercise. Our compounded Tirzepatide is prepared by FDA-registered 503A compounding pharmacies. Compounded medications are not FDA-approved and may differ in effectiveness, side effects, and risk profile compared to FDA-approved brand-name medications.
Individual results vary based on factors such as starting weight, diet, exercise habits, and adherence to treatment. Your healthcare provider will help set realistic expectations.
Key Points
- Compounded medication prepared by FDA-registered 503A pharmacies
- Compounded tirzepatide
- Dual-action: activates both GLP-1 and GIP receptors
- Helps reduce appetite and food cravings
- Available in injectable and oral dissolving tablet forms
Micro Dosing Option
For patients who prefer a gentler introduction to dual-action GLP-1/GIP therapy, TruLifeMeds offers a micro dosing option for compounded Tirzepatide. Micro dosing uses lower doses to help your body gradually adjust, potentially reducing initial side effects while still supporting your weight management goals.
Micro dosing plans are available for up to 12 months, after which your healthcare provider may recommend transitioning to standard dosing for continued progress. This option is ideal for patients who want to ease into treatment or who are sensitive to medication adjustments.
Starting at just $149/month, micro dosing provides an accessible entry point to begin your weight management journey with provider supervision and support.
Micro dosing plans are available for up to 12 months, after which your healthcare provider may recommend transitioning to standard dosing for continued progress. This option is ideal for patients who want to ease into treatment or who are sensitive to medication adjustments.
Starting at just $149/month, micro dosing provides an accessible entry point to begin your weight management journey with provider supervision and support.
Starting at $149/mo
Available Forms
Tirzepatide Injectable
Injectable
Subcutaneous injection administered as prescribed by your healthcare provider
As low as $249.00/moView Pricing →
Subcutaneous delivery method
Tirzepatide Oral Dissolving Tablets
Oral Dissolving Tablets
Needle-free oral dissolving tablets taken as prescribed by your healthcare provider
As low as $399.00/moView Pricing →
No injections required
What are the benefits of Tirzepatide?
Dual Hormone Action
Tirzepatide is unique because it activates both GLP-1 and GIP receptors simultaneously. This dual-action approach may provide enhanced appetite suppression and metabolic support compared to single-action medications.
Appetite Reduction
Tirzepatide helps reduce appetite and food cravings to support weight management goals. Individual results vary based on factors including diet, exercise, and adherence to treatment.
Metabolic Support
Beyond weight management, Tirzepatide may support blood sugar regulation, insulin sensitivity, and overall metabolic function. Your healthcare provider will monitor your progress.
Flexible Dosing Options
Tirzepatide is available as an injection or oral dissolving tablets, allowing patients to choose the delivery method that best fits their lifestyle and preferences. Your healthcare provider will determine the appropriate dosing schedule.
How does Tirzepatide work?
Tirzepatide works by mimicking two naturally occurring hormones in your body: GLP-1 and GIP. When you eat, your body normally releases these hormones to signal fullness and regulate blood sugar. Tirzepatide amplifies these signals, leading to reduced appetite and improved metabolic function.
- Activates GLP-1 receptors to reduce appetite and increase feelings of fullness
- Activates GIP receptors for enhanced metabolic control and improved insulin sensitivity
- Slows gastric emptying, so food stays in your stomach longer and you feel satisfied
- Reduces food cravings and thoughts about food between meals
- Improves how your body responds to insulin and processes blood sugar
Think of Tirzepatide as having two keys instead of one - while other medications like Semaglutide only activate the GLP-1 receptor, Tirzepatide unlocks both GLP-1 and GIP pathways for more comprehensive appetite and metabolic control.
How do I take Tirzepatide?
Injectable Form
Tirzepatide Injectable is administered as a subcutaneous (under the skin) injection. Your healthcare provider will determine the appropriate dosing schedule and guide you on proper injection technique and site rotation.
- 1Choose an injection site: abdomen, thigh, or upper arm
- 2Clean the area with an alcohol swab
- 3Inject subcutaneously at a 90-degree angle
- 4Rotate injection sites as directed to prevent irritation
- 5Follow your healthcare provider's specific dosing schedule
Oral Dissolving Tablets
Tirzepatide Oral Dissolving Tablets are taken as oral dissolving tablets as prescribed by your healthcare provider. These compounded oral dissolving tablets offer a needle-free alternative to injections.
- 1Take the tablet on an empty stomach as directed
- 2Place the tablet under your tongue and allow the tablet to dissolve
- 3Wait at least 30 minutes before eating or drinking anything
- 4Follow your healthcare provider's specific dosing schedule
- 5Follow your healthcare provider's dosing instructions
What results can I expect from Tirzepatide?
Results from Tirzepatide vary significantly based on individual factors including starting weight, diet, exercise habits, and adherence to treatment. Your healthcare provider will help set realistic expectations based on your personal health profile.
Dual
GLP-1 and GIP activation
Reduced
Appetite and cravings
Gradual
Sustainable progress
Individual
Results may vary
Results Timeline
Week 1-4
Appetite suppression may begin, reduced food cravings
Week 4-8
Initial changes may become noticeable for some patients
Week 8-16
Continued progress with consistent treatment and lifestyle changes
Week 16-24
Progress continues; provider may adjust dosing as needed
Week 24+
Long-term management with ongoing provider supervision
Comparison with Other Treatments
Tirzepatide activates both GLP-1 and GIP receptors (dual action), while Semaglutide activates only GLP-1 receptors. Both are prescribed for weight management. Your healthcare provider can help determine which option may be appropriate for your needs.
What are the side effects of Tirzepatide?
Common Side Effects
•
Nausea(Very common (especially initially))
Usually improves over 2-4 weeks as your body adjusts
•
Diarrhea(Common)
Can be managed with dietary adjustments
•
Vomiting(Common)
Typically mild and temporary
•
Constipation(Common)
Increase fiber and water intake
•
Reduced appetite(Very common)
Reduced appetite is the intended therapeutic effect
•
Abdominal pain(Common)
Usually mild and improves with time
Serious Side Effects (Seek Medical Attention)
- Thyroid tumors (C-cell carcinoma)- Boxed warning
Tell your doctor if you have family history of medullary thyroid cancer or MEN 2 syndrome
- Pancreatitis- Rare but serious
Seek immediate medical care for severe, persistent abdominal pain
- Gallbladder disease- Monitor for symptoms
Report upper right abdominal pain, especially after meals
- Kidney problems- Risk increases with dehydration
Stay well hydrated and report any urinary changes
- Severe allergic reactions- Rare
Seek emergency care for difficulty breathing, swelling, or severe rash
Tips for Managing Side Effects
- Start with the lowest dose and increase gradually as directed
- Eat smaller, more frequent meals throughout the day
- Avoid high-fat, greasy, or spicy foods that may worsen nausea
- Stay well hydrated - drink at least 8 glasses of water daily
- Take anti-nausea medication if recommended by your doctor
- Report persistent or severe side effects to your healthcare provider
What should I know about Tirzepatide?
Our compounded Tirzepatide is prepared by FDA-registered 503A compounding pharmacies. Compounded medications are not FDA-approved and may differ in side effects and risk profile compared to FDA-approved brand-name medications. Like all medications, Tirzepatide carries some risks that should be discussed with your healthcare provider.
The medication has a boxed warning regarding thyroid C-cell tumors observed in animal studies. While thyroid C-cell tumor risk has not been confirmed in humans, Tirzepatide is not recommended for patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Most side effects are gastrointestinal and tend to improve over time as your body adjusts to the medication. Your healthcare provider will start you on a low dose and gradually increase the dosage to minimize side effects.
The medication has a boxed warning regarding thyroid C-cell tumors observed in animal studies. While thyroid C-cell tumor risk has not been confirmed in humans, Tirzepatide is not recommended for patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Most side effects are gastrointestinal and tend to improve over time as your body adjusts to the medication. Your healthcare provider will start you on a low dose and gradually increase the dosage to minimize side effects.
Who Should NOT Take Tirzepatide
- ✗Personal or family history of medullary thyroid carcinoma (MTC)
- ✗Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- ✗Known hypersensitivity or allergy to Tirzepatide
- ✗Current or planned pregnancy
- ✗Breastfeeding mothers
- ✗History of pancreatitis
Drug Interactions
- Insulin and sulfonylureas - may need dose adjustment to prevent low blood sugar
- Oral contraceptives - absorption may be affected; consider alternative contraception
- Other GLP-1 receptor agonists - do not combine (Semaglutide, Liraglutide, etc.)
- Medications that slow gastric emptying - effects may be enhanced
How do I get started with Tirzepatide?
Getting started with Tirzepatide through TruLifeMeds is simple, secure, and completely online. Our process ensures you receive proper medical evaluation and ongoing support throughout your weight loss journey.
Complete Health Assessment
Answer questions about your weight loss goals, medical history, and current medications. The health assessment helps our Providers determine if Tirzepatide is right for you.
Provider Consultation
A licensed provider reviews your information and, if appropriate, prescribes Tirzepatide at the right starting dose for your needs.
Receive Your Medication
Your Tirzepatide is shipped directly to your door with complete instructions. Our team is available for ongoing support and questions.
What's Included with Your Prescription
- licensed provider consultation and prescription
- Free priority shipping with tracking
- Medication supply (injectable or oral dissolving tablets)
- Injection supplies if applicable (syringes, alcohol swabs)
- Comprehensive weight management guidance
- Ongoing provider support and follow-up care
- Access to our nurse team for questions
Who should take Tirzepatide?
Ideal Candidates
- Adults with BMI of 30 or higher (obesity)
- Adults with BMI of 27 or higher with weight-related health conditions (high blood pressure, type 2 diabetes, high cholesterol)
- Those who have struggled with diet and exercise alone
- People seeking greater weight loss than single-action medications
- Individuals committed to long-term lifestyle changes alongside medication
- Those who prefer needle-free options (oral dissolving tablets available)
Not Recommended For
- ✗Those with personal or family history of medullary thyroid cancer
- ✗People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- ✗Pregnant or breastfeeding women
- ✗Those with a history of pancreatitis
- ✗People with severe gastrointestinal disease
- ✗Those allergic to Tirzepatide or any of Tirzepatide's ingredients
Frequently Asked Questions
Tirzepatide activates both GLP-1 and GIP receptors (dual action), while Semaglutide only activates GLP-1. Both are prescribed for weight management, and individual results vary. Your healthcare provider can help determine which option may be appropriate based on your individual health profile and goals.
Yes, you can switch between forms under medical supervision. Your healthcare provider will adjust your dosing appropriately. Some patients start with oral dissolving tablets and switch to injectable for enhanced results, while others prefer the convenience of tablets. Note that injectable Tirzepatide may provide slightly better results than the oral form.
Tirzepatide is typically used as a long-term treatment for weight management. Studies show that stopping the medication often results in weight regain. Most healthcare providers recommend continued use as long as you are benefiting from and tolerating the medication. Your provider will work with you to determine the best long-term plan.
If you miss a dose of Tirzepatide, contact your healthcare provider for guidance on how to proceed. Your provider will determine the appropriate action based on your specific dosing schedule. Never take a double dose to make up for a missed dose.
Studies show that some weight regain is common after discontinuing Tirzepatide or other GLP-1/GIP medications. Because of rebounding weight gain upon discontinuation, most providers recommend long-term use and emphasize developing healthy eating and exercise habits while on the medication. These lifestyle changes can help minimize regain if you ever stop the medication.
FDA-approved brand-name GLP-1/GIP medications are manufactured by pharmaceutical companies and undergo the full FDA approval process. Our compounded Tirzepatide is prepared by FDA-registered 503A pharmacies. Compounded medications are not FDA-approved and may differ in effectiveness, side effects, and risk profile compared to FDA-approved brand-name medications.
Most patients notice reduced appetite within the first 1-2 weeks. Visible weight loss typically begins around week 4-8. Optimal results are seen after 6-12 months of consistent treatment. Individual results vary based on starting weight, dosing, diet, and exercise.
GLP-1/GIP receptor agonists are an FDA-approved class of medications used for type 2 diabetes treatment. Tirzepatide helps control blood sugar while promoting weight loss. Before starting Tirzepatide, consult with your medical provider to adjust or discontinue any current diabetes medications you are taking. Consulting your medical provider is essential to prevent dangerously low blood sugar levels. Tirzepatide is not recommended for type 1 diabetes.
Medical Disclaimer: Our Tirzepatide is a compounded medication prepared by FDA-registered 503A compounding pharmacies and is not FDA-approved. Compounded medications may differ in effectiveness, side effects, and risk profile compared to FDA-approved brand-name medications. May cause nausea, vomiting, diarrhea, and constipation. Serious side effects may include thyroid tumors, pancreatitis, and gallbladder disease. Not recommended for those with a personal or family history of medullary thyroid cancer or MEN 2 syndrome. Always consult a healthcare provider before starting any new medication.
This is a compounded medication that requires a prescription from a licensed healthcare provider. Only a healthcare provider can determine if a compounded medication is appropriate for your care. Learn more about our pharmacy partners.
Related Prescriptions
Semaglutide (Injectable)
GLP-1 receptor agonist for weight management. Helps reduce appetite, minimize food cravings, and support metabolic function. Compounded by FDA-registered 503A pharmacies. Individual results vary.
As low as $199.00/moLearn More →
Semaglutide (Oral Dissolving Tablets)
Needle-free GLP-1 medication for weight loss. Compounded semaglutide in convenient oral dissolving tablets for appetite control and metabolic support.
As low as $345.00/moLearn More →
Semaglutide (Sublingual Drops)
Liquid GLP-1 medication for weight loss. Compounded semaglutide sublingual drops provide an alternative to tablets or injections for those who prefer sublingual administration.
As low as $345.00/moLearn More →
Ready to Get Started with Tirzepatide?
Choose the form that works best for you and begin your journey today.
Tirzepatide Injectable
Subcutaneous injection administered as prescribed by your healthcare provider
Tirzepatide Oral Dissolving Tablets
Needle-free oral dissolving tablets taken as prescribed by your healthcare provider